ArticleScientific reports2025
Graphene-cobalt hexacyanoferrate modified sensor doped with molecularly imprinted polymer for selective potentiometric determination of bupropion.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents the first application of a graphene/cobalt hexacyanoferrate composite as an ion-to-electron transducer interlayer for the selective electrochemical determination of bupropion. The composite was prepared by homogeneously dispersing graphene with tween 80 and then decorating it with cobalt-hexacyanoferrate nanoparticles. Modifying glassy carbon electrodes with this interlayer improved and stabilized the measured potential by preventing the formation of an aqueous layer beneath the sensing membrane and enhancing charge transfer. The formation of the aqueous layer is a phenomenon commonly associated with solid-contact ion-selective electrodes. These electrodes encounter challenges regarding selectivity affecting their analytical performance in the presence of ions with similar charges and proper lipophilicity. Molecularly imprinted polymer (MIP) approach was employed to resolve the selectivity problem of analyzing bupropion in presence of naltrexone for obesity management. Scanning electron microscope and Fourier-transform infrared were utilized to characterize the fabricated composite and the MIP. Two cationic exchangers were separately integrated with the precipitated MIP to produce sensors for selective determination of bupropion in the dosage form and in spiked human plasma. The sensors exhibited Nernstian slope of 54.66 mV/decade and 55.89 mV/decade with detection limits as low as 2.51 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.